FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4296808300> ?p ?o ?g. }

• W4296808300 endingPage "115" @default.
• W4296808300 startingPage "104" @default.
• W4296808300 abstract "Lenvatinib is used to treat advanced hepatocellular carcinoma (HCC). Metabolic dysfunction-associated fatty liver disease (MAFLD) is becoming a major etiology of HCC. We aimed to evaluate the impact of MAFLD on the efficacy of lenvatinib.We enrolled 320 patients with HCC who were treated with lenvatinib. All patients were classified into the MAFLD (n = 155) and non-MAFLD (n = 165) groups. Independent factors for overall survival (OS) were analyzed. In the stratification analysis, HCC was categorized as non-viral (n = 115) or viral HCC (n = 205).The OS rate was significantly higher in the MAFLD group than in the non-MAFLD group (median 21.1 vs. 15.1 months, p = 0.002). Multivariate analysis demonstrated that, in addition to albumin-bilirubin grade and Barcelona Clinic Liver Cancer stage, MAFLD was identified as an independent factor for OS (HR 0.722, 95% CI 0.539-0.966, p = 0.028). In the stratification analysis, the OS rate was significantly higher in the MAFLD group than in the non-MAFLD group among patients with non-viral HCC (median 21.1 vs. 15.1 months, p = 0.002), but not in patients with viral HCC. Furthermore, MAFLD was an independent negative risk factor for OS in patients with non-viral HCC (HR 0.506, 95% CI 0.297-0.864, P < 0.01). However, MAFLD was not an independent factor for OS in patients with viral HCC.MAFLD was a beneficial factor for survival in patients with HCC treated with lenvatinib. Moreover, the better OS of the MAFLD group was more pronounced in patients with non-viral HCC. Lenvatinib may be a suitable agent for patients with non-viral HCC and MAFLD." @default.
• W4296808300 created "2022-09-24" @default.
• W4296808300 creator A5003031164 @default.
• W4296808300 creator A5005361135 @default.
• W4296808300 creator A5006354271 @default.
• W4296808300 creator A5008593372 @default.
• W4296808300 creator A5012513340 @default.
• W4296808300 creator A5013194037 @default.
• W4296808300 creator A5016855346 @default.
• W4296808300 creator A5019517417 @default.
• W4296808300 creator A5021212136 @default.
• W4296808300 creator A5022957505 @default.
• W4296808300 creator A5033954465 @default.
• W4296808300 creator A5037691579 @default.
• W4296808300 creator A5038742680 @default.
• W4296808300 creator A5040485741 @default.
• W4296808300 creator A5043893197 @default.
• W4296808300 creator A5049569407 @default.
• W4296808300 creator A5054687903 @default.
• W4296808300 creator A5063172369 @default.
• W4296808300 creator A5066125776 @default.
• W4296808300 creator A5074219274 @default.
• W4296808300 creator A5083997418 @default.
• W4296808300 creator A5084839932 @default.
• W4296808300 creator A5086674791 @default.
• W4296808300 date "2022-11-06" @default.
• W4296808300 modified "2023-10-05" @default.
• W4296808300 title "The beneficial impact of metabolic dysfunction‐associated fatty liver disease on lenvatinib treatment in patients with non‐viral hepatocellular carcinoma" @default.
• W4296808300 cites W1993716916 @default.
• W4296808300 cites W2094109552 @default.
• W4296808300 cites W2136057321 @default.
• W4296808300 cites W2887374379 @default.
• W4296808300 cites W2888056309 @default.
• W4296808300 cites W2894724600 @default.
• W4296808300 cites W2939267996 @default.
• W4296808300 cites W2945004896 @default.
• W4296808300 cites W2998980069 @default.
• W4296808300 cites W3004644667 @default.
• W4296808300 cites W3015579983 @default.
• W4296808300 cites W3019539163 @default.
• W4296808300 cites W3025022288 @default.
• W4296808300 cites W3026099517 @default.
• W4296808300 cites W3042394484 @default.
• W4296808300 cites W3089758949 @default.
• W4296808300 cites W3092649258 @default.
• W4296808300 cites W3101469763 @default.
• W4296808300 cites W3128646645 @default.
• W4296808300 cites W3165273733 @default.
• W4296808300 cites W3165407607 @default.
• W4296808300 cites W3167550451 @default.
• W4296808300 cites W3183857127 @default.
• W4296808300 cites W3184822373 @default.
• W4296808300 cites W3193129223 @default.
• W4296808300 cites W3196841519 @default.
• W4296808300 cites W3208523563 @default.
• W4296808300 cites W3211458801 @default.
• W4296808300 cites W4200547311 @default.
• W4296808300 cites W4212810587 @default.
• W4296808300 cites W4281695324 @default.
• W4296808300 cites W4285011106 @default.
• W4296808300 doi "https://doi.org/10.1111/hepr.13843" @default.
• W4296808300 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36149726" @default.
• W4296808300 hasPublicationYear "2022" @default.
• W4296808300 type Work @default.
• W4296808300 citedByCount "8" @default.
• W4296808300 countsByYear W42968083002023 @default.
• W4296808300 crossrefType "journal-article" @default.
• W4296808300 hasAuthorship W4296808300A5003031164 @default.
• W4296808300 hasAuthorship W4296808300A5005361135 @default.
• W4296808300 hasAuthorship W4296808300A5006354271 @default.
• W4296808300 hasAuthorship W4296808300A5008593372 @default.
• W4296808300 hasAuthorship W4296808300A5012513340 @default.
• W4296808300 hasAuthorship W4296808300A5013194037 @default.
• W4296808300 hasAuthorship W4296808300A5016855346 @default.
• W4296808300 hasAuthorship W4296808300A5019517417 @default.
• W4296808300 hasAuthorship W4296808300A5021212136 @default.
• W4296808300 hasAuthorship W4296808300A5022957505 @default.
• W4296808300 hasAuthorship W4296808300A5033954465 @default.
• W4296808300 hasAuthorship W4296808300A5037691579 @default.
• W4296808300 hasAuthorship W4296808300A5038742680 @default.
• W4296808300 hasAuthorship W4296808300A5040485741 @default.
• W4296808300 hasAuthorship W4296808300A5043893197 @default.
• W4296808300 hasAuthorship W4296808300A5049569407 @default.
• W4296808300 hasAuthorship W4296808300A5054687903 @default.
• W4296808300 hasAuthorship W4296808300A5063172369 @default.
• W4296808300 hasAuthorship W4296808300A5066125776 @default.
• W4296808300 hasAuthorship W4296808300A5074219274 @default.
• W4296808300 hasAuthorship W4296808300A5083997418 @default.
• W4296808300 hasAuthorship W4296808300A5084839932 @default.
• W4296808300 hasAuthorship W4296808300A5086674791 @default.
• W4296808300 hasConcept C126322002 @default.
• W4296808300 hasConcept C143998085 @default.
• W4296808300 hasConcept C2776231280 @default.
• W4296808300 hasConcept C2776264508 @default.
• W4296808300 hasConcept C2777072776 @default.
• W4296808300 hasConcept C2778019345 @default.
• W4296808300 hasConcept C2778695046 @default.
• W4296808300 hasConcept C2778772119 @default.

• next